 | • レポートコード：D0GIR-03632 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、運動促進薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。運動促進薬の種類別市場規模（メトクロプラミド、ドンペリドン、シサプリド、その他）、用途別市場規模（胃不全麻痺、便秘、逆流性食道炎、機能性消化不良）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sumitomo、Hanmi Pharm、Kyowa Kirin Pharmaceuticals、Johnson & Johnson、Cadila Pharmaceuticals、Sanofi、Teva、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・運動促進薬の北米市場（アメリカ、カナダ、メキシコ） ・運動促進薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・運動促進薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・運動促進薬の南米市場（ブラジル、アルゼンチン） ・運動促進薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：メトクロプラミド、ドンペリドン、シサプリド、その他 ・用途別分析：胃不全麻痺、便秘、逆流性食道炎、機能性消化不良 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Prokinetic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Prokinetic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Prokinetic Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prokinetic Drug market has been segmented into
Metoclopramide
Domperidone
Cisapride
Others
By Application, Prokinetic Drug has been segmented into:
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prokinetic Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Prokinetic Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prokinetic Drug market.
The report offers in-depth assessment of the growth and other aspects of the Prokinetic Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prokinetic Drug Market Share Analysis
Prokinetic Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prokinetic Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prokinetic Drug sales, revenue and market share for each player covered in this report.
The major players covered in Prokinetic Drug are:
Sumitomo
Hanmi Pharm
Kyowa Kirin Pharmaceuticals
Johnson & Johnson
Cadila Pharmaceuticals
Sanofi
Teva
Pfizer
Among other players domestic and global, Prokinetic Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prokinetic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prokinetic Drug, with price, sales, revenue and global market share of Prokinetic Drug in 2018 and 2019.
Chapter 3, the Prokinetic Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prokinetic Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prokinetic Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prokinetic Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prokinetic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prokinetic Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prokinetic Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Overview of Global Prokinetic Drug Market
1.4.1 Global Prokinetic Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sumitomo
2.1.1 Sumitomo Details
2.1.2 Sumitomo Major Business
2.1.3 Sumitomo SWOT Analysis
2.1.4 Sumitomo Product and Services
2.1.5 Sumitomo Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hanmi Pharm
2.2.1 Hanmi Pharm Details
2.2.2 Hanmi Pharm Major Business
2.2.3 Hanmi Pharm SWOT Analysis
2.2.4 Hanmi Pharm Product and Services
2.2.5 Hanmi Pharm Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kyowa Kirin Pharmaceuticals
2.3.1 Kyowa Kirin Pharmaceuticals Details
2.3.2 Kyowa Kirin Pharmaceuticals Major Business
2.3.3 Kyowa Kirin Pharmaceuticals SWOT Analysis
2.3.4 Kyowa Kirin Pharmaceuticals Product and Services
2.3.5 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cadila Pharmaceuticals
2.5.1 Cadila Pharmaceuticals Details
2.5.2 Cadila Pharmaceuticals Major Business
2.5.3 Cadila Pharmaceuticals SWOT Analysis
2.5.4 Cadila Pharmaceuticals Product and Services
2.5.5 Cadila Pharmaceuticals Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Product and Services
2.6.4 Sanofi Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Product and Services
2.7.4 Teva Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prokinetic Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prokinetic Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prokinetic Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Prokinetic Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prokinetic Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Prokinetic Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prokinetic Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Prokinetic Drug Sales and Growth Rate (2015-2020)
4.3 Europe Prokinetic Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prokinetic Drug Sales and Growth Rate (2015-2020)
4.5 South America Prokinetic Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prokinetic Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prokinetic Drug Sales, Revenue and Market Share by Country
5.1.1 North America Prokinetic Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Prokinetic Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Prokinetic Drug Sales and Growth Rate (2015-2020)
5.3 Canada Prokinetic Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Prokinetic Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prokinetic Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Prokinetic Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prokinetic Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Prokinetic Drug Sales and Growth Rate (2015-2020)
6.3 UK Prokinetic Drug Sales and Growth Rate (2015-2020)
6.4 France Prokinetic Drug Sales and Growth Rate (2015-2020)
6.5 Russia Prokinetic Drug Sales and Growth Rate (2015-2020)
6.6 Italy Prokinetic Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prokinetic Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prokinetic Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prokinetic Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Prokinetic Drug Sales and Growth Rate (2015-2020)
7.3 Japan Prokinetic Drug Sales and Growth Rate (2015-2020)
7.4 Korea Prokinetic Drug Sales and Growth Rate (2015-2020)
7.5 India Prokinetic Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prokinetic Drug Sales and Growth Rate (2015-2020)
7.7 Australia Prokinetic Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prokinetic Drug Sales, Revenue and Market Share by Country
8.1.1 South America Prokinetic Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Prokinetic Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prokinetic Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Prokinetic Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prokinetic Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prokinetic Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prokinetic Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prokinetic Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Prokinetic Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Prokinetic Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Prokinetic Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prokinetic Drug Sales and Market Share by Type (2015-2020)
10.2 Global Prokinetic Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Prokinetic Drug Price by Type (2015-2020)
11 Global Prokinetic Drug Market Segment by Application
11.1 Global Prokinetic Drug Sales Market Share by Application (2015-2020)
11.2 Global Prokinetic Drug Revenue Market Share by Application (2015-2020)
11.3 Global Prokinetic Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prokinetic Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Prokinetic Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Prokinetic Drug Market Forecast (2021-2025)
12.2.2 Europe Prokinetic Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prokinetic Drug Market Forecast (2021-2025)
12.2.4 South America Prokinetic Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prokinetic Drug Market Forecast (2021-2025)
12.3 Prokinetic Drug Market Forecast by Type (2021-2025)
12.3.1 Global Prokinetic Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Prokinetic Drug Market Share Forecast by Type (2021-2025)
12.4 Prokinetic Drug Market Forecast by Application (2021-2025)
12.4.1 Global Prokinetic Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Prokinetic Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prokinetic Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prokinetic Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prokinetic Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Prokinetic Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sumitomo Basic Information, Manufacturing Base and Competitors
Table 9. Sumitomo Prokinetic Drug Major Business
Table 10. Sumitomo Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 11. Sumitomo SWOT Analysis
Table 12. Sumitomo Prokinetic Drug Product and Services
Table 13. Sumitomo Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Hanmi Pharm Basic Information, Manufacturing Base and Competitors
Table 15. Hanmi Pharm Prokinetic Drug Major Business
Table 16. Hanmi Pharm Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 17. Hanmi Pharm SWOT Analysis
Table 18. Hanmi Pharm Prokinetic Drug Product and Services
Table 19. Hanmi Pharm Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Kyowa Kirin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 21. Kyowa Kirin Pharmaceuticals Prokinetic Drug Major Business
Table 22. Kyowa Kirin Pharmaceuticals Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 23. Kyowa Kirin Pharmaceuticals SWOT Analysis
Table 24. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product and Services
Table 25. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 27. Johnson & Johnson Prokinetic Drug Major Business
Table 28. Johnson & Johnson Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 29. Johnson & Johnson SWOT Analysis
Table 30. Johnson & Johnson Prokinetic Drug Product and Services
Table 31. Johnson & Johnson Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 33. Cadila Pharmaceuticals Prokinetic Drug Major Business
Table 34. Cadila Pharmaceuticals Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 35. Cadila Pharmaceuticals SWOT Analysis
Table 36. Cadila Pharmaceuticals Prokinetic Drug Product and Services
Table 37. Cadila Pharmaceuticals Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Prokinetic Drug Major Business
Table 40. Sanofi Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 41. Sanofi SWOT Analysis
Table 42. Sanofi Prokinetic Drug Product and Services
Table 43. Sanofi Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Teva Basic Information, Manufacturing Base and Competitors
Table 45. Teva Prokinetic Drug Major Business
Table 46. Teva Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 47. Teva SWOT Analysis
Table 48. Teva Prokinetic Drug Product and Services
Table 49. Teva Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Pfizer Basic Information, Manufacturing Base and Competitors
Table 51. Pfizer Prokinetic Drug Major Business
Table 52. Pfizer Prokinetic Drug Total Revenue (USD Million) (2018-2019)
Table 53. Pfizer SWOT Analysis
Table 54. Pfizer Prokinetic Drug Product and Services
Table 55. Pfizer Prokinetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Prokinetic Drug Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Prokinetic Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Prokinetic Drug Sales by Regions (2015-2020) (K Units)
Table 59. Global Prokinetic Drug Sales Market Share by Regions (2015-2020)
Table 60. Global Prokinetic Drug Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Prokinetic Drug Sales by Countries (2015-2020) (K Units)
Table 62. North America Prokinetic Drug Sales Market Share by Countries (2015-2020)
Table 63. North America Prokinetic Drug Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Prokinetic Drug Revenue Market Share by Countries (2015-2020)
Table 65. Europe Prokinetic Drug Sales by Countries (2015-2020) (K Units)
Table 66. Europe Prokinetic Drug Sales Market Share by Countries (2015-2020)
Table 67. Europe Prokinetic Drug Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Prokinetic Drug Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Prokinetic Drug Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Prokinetic Drug Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Prokinetic Drug Sales by Countries (2015-2020) (K Units)
Table 72. South America Prokinetic Drug Sales Market Share by Countries (2015-2020)
Table 73. South America Prokinetic Drug Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Prokinetic Drug Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Prokinetic Drug Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Prokinetic Drug Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Prokinetic Drug Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Prokinetic Drug Revenue Market Share by Countries (2015-2020)
Table 79. Global Prokinetic Drug Sales by Type (2015-2020) (K Units)
Table 80. Global Prokinetic Drug Sales Share by Type (2015-2020)
Table 81. Global Prokinetic Drug Revenue by Type (2015-2020) (USD Million)
Table 82. Global Prokinetic Drug Revenue Share by Type (2015-2020)
Table 83. Global Prokinetic Drug Sales by Application (2015-2020) (K Units)
Table 84. Global Prokinetic Drug Sales Share by Application (2015-2020)
Table 85. Global Prokinetic Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Prokinetic Drug Market Share Forecast by Regions (2021-2025)
Table 87. Global Prokinetic Drug Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Prokinetic Drug Market Share Forecast by Type (2021-2025)
Table 89. Global Prokinetic Drug Sales Forecast by Application (2021-2025)
Table 90. Global Prokinetic Drug Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prokinetic Drug Picture
Figure 2. Global Sales Market Share of Prokinetic Drug by Type in 2019
Figure 3. Metoclopramide Picture
Figure 4. Domperidone Picture
Figure 5. Cisapride Picture
Figure 6. Others Picture
Figure 7. Prokinetic Drug Sales Market Share by Application in 2019
Figure 8. Gastroparesis Picture
Figure 9. Constipation Picture
Figure 10. Reflux Esophagitis Picture
Figure 11. Functional Dyspepsia Picture
Figure 12. Global Prokinetic Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Prokinetic Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Prokinetic Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Prokinetic Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Prokinetic Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Prokinetic Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Prokinetic Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Prokinetic Drug Revenue Market Share by Regions in 2018
Figure 41. North America Prokinetic Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Prokinetic Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Prokinetic Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Prokinetic Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Prokinetic Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Prokinetic Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Prokinetic Drug Sales Market Share by Countries in 2018
Figure 49. North America Prokinetic Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Prokinetic Drug Revenue Market Share by Countries in 2018
Figure 51. United States Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Prokinetic Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Prokinetic Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Prokinetic Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Prokinetic Drug Revenue Market Share by Regions 2019
Figure 65. China Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Prokinetic Drug Sales Market Share by Countries in 2019
Figure 72. South America Prokinetic Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Prokinetic Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Prokinetic Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Prokinetic Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Prokinetic Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Prokinetic Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Prokinetic Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Prokinetic Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Prokinetic Drug Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Prokinetic Drug Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Prokinetic Drug Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Prokinetic Drug Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Prokinetic Drug Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
糖尿病性胃不全麻痺薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Diabetic Gastroparesis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 特発性胃不全麻痺薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Idiopathic Gastroparesis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 胃抗分泌薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Gastric Antisecretory Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 抗コリン薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Anticholinergic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …